Skip to main content
Livermore
Livermore
ZHEN

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overviewAll 13F holders of LGNDFull Q2 2026 holdings

Shares (Q2 2026)
8,284
Value
$2.62M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of LGND by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20268,284$2.62M<0.1%−2,849−25.6%ReducedHolders
Q1 202611,133$2.22M<0.1%+4,517+68.3%AddedHolders
Q4 20256,616$1.25M<0.1%+29+0.4%AddedHolders
Q3 20256,587$1.17M<0.1%+1,278+24.1%AddedHolders
Q2 20255,309$603.5K<0.1%+9+0.2%AddedHolders
Q1 20255,300$557.2K<0.1%−242−4.4%ReducedHolders
Q4 20245,542$593.8K<0.1%+400+7.8%AddedHolders
Q3 20245,142$518.0K<0.1%+266+5.5%AddedHolders
Q2 20244,876$412.0K<0.1%+262+5.7%AddedHolders
Q1 20244,614$337.0K<0.1%00.0%UnchangedHolders
Q4 20234,614$329.0K<0.1%+47+1.0%AddedHolders
Q3 20234,567$275.0K<0.1%+1,675+57.9%AddedHolders
Q2 20232,892$208.0K<0.1%+122+4.4%AddedHolders
Q1 20232,770$203.0K<0.1%+2,770NewHolders
Q4 20220$00.0%−2,967−100.0%Sold outHolders
Q3 20222,967$256.0K<0.1%+3+0.1%AddedHolders
Q2 20222,964$265.0K<0.1%00.0%UnchangedHolders
Q1 20222,964$333.0K<0.1%−77−2.5%ReducedHolders
Q4 20213,041$469.0K<0.1%+18+0.6%AddedHolders
Q3 20213,023$419.0K<0.1%+20+0.7%AddedHolders
Q2 20213,003$394.0K<0.1%−9−0.3%ReducedHolders
Q1 20213,012$458.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.